Slingsby Brian Taylor Insider Trades & Stock Holdings

Director · Mineralys Therapeutics, Inc. · Latest filing Sep 22, 2026

Slingsby Brian Taylor, Director at Mineralys Therapeutics, Inc. has 1 Form 4 trade on file since Sep 22, 2026. Open-market activity: 0 purchases ($0) and 1 sale ($3.01M), net -$3.01M. Latest filing: disposed of 104.32K shares of $MLYS on Sep 22, 2026 at $28.81.

Trades on file

1

Open-market bought

$0

Open-market sold

$3.01M

Net open-market

-$3.01M

Latest filing

Sep 22, 2026

All insider trades by Slingsby Brian Taylor

Date	Ticker	Type	Shares	Price	Value	Owned after	ΔOwn	1W	1M	6M	Role	Filing	Story
Sep 22, 2026	$MLYS	Sell (Open-market sale)	104.32K	$28.81	$3.01M			-16.7%			Director		—

"Buy" means shares acquired on the Form 4 (including grants and option exercises); "Sell" means shares disposed. 1W / 1M / 6M = how the stock moved after the trade.

Stocks Slingsby Brian Taylor traded

• $MLYS

Frequently asked questions

Has Slingsby Brian Taylor been buying or selling stock?

Slingsby Brian Taylor has 0 open-market purchases and 1 open-market sale on file, net -$3.01M. Grants, option exercises and tax withholding are listed separately because they are not open-market trades.

What was Slingsby Brian Taylor's latest insider trade?

disposed of 104.32K shares of $MLYS on Sep 22, 2026 at $28.81.

Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.